News Agency
The Times

NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for the Treatment of Schizophrenia

  • Written by PR Newswire

SHANGHAI and LEXINGTON, Mass. , May 8, 2024 /PRNewswire/ -- NeuShen Therapeutics (the "Company"), a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today announced the dosing of the first healthy volunteer in Australia in the Phase I first-in-human clinical trial of...

Read more: NeuShen Therapeutics Initiates First-in-Human Trial of NS-136, a Novel Selective M4 Receptor...

Why Commercial Waste Management Is Important For Modern Businesses

Businesses across many industries generate large amounts of waste every day through operations, packaging, manufacturing, customer activity, and general workplace use. Many organisations now depend on professional commercial waste management services to maintain cleaner workplaces, improve operational efficiency, and support environmentally... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion